Why Everyone Is Watching Sherwin Williams (SHW) Right Now

Krylon, a Sherwin-Williams (SHW) brand, has introduced Krylon Harmony, a water-based spray paint designed to reduce odor, flammability concerns and overspray, and to support indoor and year-round DIY projects.

See our latest analysis for Sherwin-Williams.

The new Krylon Harmony launch comes as Sherwin-Williams’ share price trades at US$346.59, with a 30-day share price return of 8.34% and a 90-day share price return of 12.14%. The 3-year total shareholder return of 34.50% contrasts with a 1-year total shareholder return that declined 6.18%, suggesting longer term holders have seen gains even as recent momentum has cooled.

If this type of product news has you thinking more broadly about materials and coatings opportunities, it can be useful to cast a wider net and review 21 top founder-led companies

For Sherwin-Williams, a 12.14% 90 day gain alongside a 1 year total return that declined 6.18% raises a key issue: Is price now tracking business progress, or a swing in sentiment that the valuation section needs to unpack next?

Most Popular Narrative: 11.2% Undervalued

The most followed narrative compares Sherwin-Williams' fair value of $390.10 to the current $346.59 share price, framing Krylon Harmony within a broader earnings and margin story that extends well beyond a single product launch.

The company's sustained focus on cost control, broad and deep restructuring (doubling annual savings targets to ~$80 million), and disciplined SG&A management is structurally improving fixed cost leverage and expected to yield improved net margins and earnings power as sales volumes recover.

Read the complete narrative. Read the complete narrative.

Want to understand why this fair value sits above today's price? The narrative leans heavily on steady revenue expansion, firmer profit margins, and a premium earnings multiple. The key is how these three levers are expected to work together over the next few years without assuming explosive growth.

Result: Fair Value of $390.10 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Sherwin-Williams still faces weak demand in key housing related markets and relies heavily on North America. As a result, a slower recovery could challenge the current undervalued narrative.

Find out about the key risks to this Sherwin-Williams narrative.

Another View On Sherwin-Williams Valuation

The narrative fair value suggests Sherwin-Williams is 11.2% undervalued at $390.10 versus the current $346.59 share price. Yet on a simple P/E basis of 31.1x, the stock looks expensive compared with the US Chemicals industry at 23.6x, peers at 29.2x, and a fair ratio of 21.5x. This raises the question of whether the premium reflects comfort with the story, or a valuation risk that could matter if sentiment shifts.

For a closer look at how this pricing gap compares with earnings fundamentals, our valuation work breaks down what the numbers imply for future returns and risk using the fair ratio as a reference point. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If the mixed tone on Sherwin-Williams has you torn, now is a good time to review the data, weigh the trade offs, and sharpen your own thesis using 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Sherwin-Williams?

Do not stop at Sherwin-Williams. Broaden your watchlist with focused stock ideas that match different goals, so you are not relying on a single story.

• Target steady potential by scanning for companies built on strong finances with the solid balance sheet and fundamentals stocks screener (50 results)
• Hunt for quality at a discount by reviewing the screener containing 19 high quality undiscovered gems before others catch on.
• Prioritize resilience and sleep-better-at-night holdings by checking the 78 resilient stocks with low risk scores

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com